and chronic hepatocellular disease (Eletheriou et al. 1977) , and the protein may in these circumstances alter immune reactivity. Alpha2-macroglobulin is also produced by the liver (Hochwald et al. 1961 ) and has immunosuppressant properties (Cooperband et al. 1972 ). In the field of complement metabolism some kinetic studies are available, they indicate that although increased immune catabolism may -occur in some disease groups (Potter et al. 1976) the major cause of diminished serum concentrations of C3 is diminished synthesis, presumably as a result of reduced hepatic cell mass (Thomas, Elias, Potter & Sherlock, in preparation) . It is probable that the synthesis of other complement components which are normally produced in the liver, will also be reduced.
Conclusion
The hypergammaglobulintmia and diminished cell-mediated immunity that are associated with chronic liver disease of diverse mtiologies, are in large part attributable to the changed state of the mononuclear phagocytic system that exists in these subjects. Although the emphasis has been placed on delineating the changes which are secondary to liver damage, this approach also serves to highlight certain phenomena which are peculiar to one disease state and therefore probably more closely related to the basic pathogenesis of that disease. In this respect, the selectively increased response of lupoid hepatitis patients to the measles virus becomes apparent, and may indicate either the presence of immune response genes or an immune defect which modifies the subjects' response not only to measles virus but also possibly to hepatitic agents. Furthermore, although the phenomenon of hyperglobulinwmia is common to most patients with chronic liver disease and is unrelated to atiology, the increased IgM in primary biliary cirrhosis and IgA in alcohol-induced disease are specific associations and may give further clues to the primary pathogenetic mechanisms in these diseases. The more generalized defects which are common to all patients may also be important in relation to the susceptibility of cirrhosis patients to infections. Hypergammaglobulinemia is a feature of many chronic liver diseases, particularly when cirrhosis has developed. Recent evidence suggests that this may be due to a failure of hepatic sequestration of antigenic material, which is then deposited in increased concentrations at sites of antibody production such as the spleen. However, in one of the chronic liver diseases, HBsAg-negative chronic active hepatitis, a markedly increased serum gammaglobulin level is a constant feature, even in patients who have not yet developed cirrhosis. The evidence suggests that in many of these patients there is a genetically determined increase in immune responsiveness.
Family studies have shown that many of the first degree relatives of patients with HBsAg-negative chronic active hepatitis have raised serum gammaglobulin levels in the absence of any clinical or biochemical signs of liver disease (Galbraith et al. 1974) , and this is compelling evidence against the hypothesis that the hypergammaglobulinemia in the patients is entirely secondary to liver damage. Such familial abnormalities could, ofcourse, be the result of powerful environmental factors and do not, of themselves, indicate a genetic influence. However, more significant evidence in favour of such an inherited predisposition is the finding that more than 60 % of the patients possess the same histocompatibility antigen, HLA-B8 (Mackay & Morris 1972) .
Association between HLA-B8 and Increased Immune Responsiveness
The mechanisms responsible for the associations between particular histocompatibility antigens and certain diseases are almost entirely unknown and hypotheses have multiplied. Animal work has linked histocompatibility antigens with genes controlling immune responses to certain simple antigens, the immune response (IR) genes (Benacerraf & Katz 1975) , and since aberrent immune responses seem to be a common feature of many of the HLA-B8 associated diseases in man, a popular hypothesis has been that IR genes linked to HLA-B8 are responsible for promoting immune responses to specific tissue antigens. The large number of diseases linked with HLA-B8 (Table 1) and the wide range of target antigens involved, from the acetyl choline receptor in myasthenia gravis (Richman et al. 1976 ) to gluten in cceliac disease, must make such an antigen-specific mech- Although the patient's mother had died bejore this study the histocompatibility antigen distribution in otherfJamily members clearly showed that the HLA-AJ, B8 haplotype had been transmittedfrom mother to daughter anism extremely unlikely unless a different IR gene was associated with HLA-B8 in each disease. However, the results of one of our family studies are clearly inconsistent with this idea (Fig 1) . The patient, a young woman with chronic active hepatitis, had inherited the haplotype HLA-A1,B8 from her mother who had been treated for thyrotoxicosis. Thus inheritance of this same haplotype seemed to have predisposed to the development of two of the HLA-B8 associated diseases, chronic active hepatitis and thyrotoxicosis. Studies of the distribution of D-locus antigens and the Blymphocyte alloantigens in the various HLA-B8 associated conditions should give a definitive answer but if, as seems likely, the relevant HLAassociated genes prove to be identical in these diseases, then an antigen nonspecific increase in immune responsiveness seems a more likely link. Several additional pieces of evidence also point towards this conclusion. Thus, HLA-B8 is associated with a high graft rejection rate in recipients of parental kidney grafts (Mickey et al. 1971 ) and confers an increased ability to eliminate the hepatitis B virus in patients whose immune responsiveness has been impaired by chronic renal failure (Bach et al. 1975 ). Furthermore, by using a standardized preparation of stimulating cells in a mixed lymphocyte reaction, Osaba & Falk (1976) have shown that HLA-B8 positive lymphocytes have increased responsiveness in vitro. Many patients with chronic active hepatitis have antibodies to measles and rubella in very high titre without evidence of recent infection (Triger et al. 1972) and it seemed possible that this might be the result of a generalized defect in the control of antibody production. We therefore examined the relation between the presence of particular histocompatibility antigens and the titre of antibodies to rubella, measles, smooth muscle, nuclei and E. coli in 49 patients with HBsAg-negative chronic active hepatitis and in the family members of some of these cases. In patients with HLA-B8, the mean titres of all antibodies were higher than in those without this histocompatibility antigen and in the case of rubella antibodies the difference was statistically significant (Galbraith et al. 1976 ). Only (Galbraith et al. 1976) one other second locus histocompatibility antigen, HLA-B 12 was associated with a similar increase in antibody titres, particularly measles and antinuclear antibodies. There seemed to be a synergistic effect when HLA-B8 and HLA-B12 were present together (Fig 2) . E. coli antibody titres were not significantly related to any ofthe histocompatibility antigens but were clearly influenced by the degree of portosystemic shunting, a significant positive correlation being found between the E. coli antibody titre and the peak count rate over the spleen on a technetium sulphur colloid scintiscan (Galbraith et al. 1976) .
In the family studies, 17 first-degree relatives, 7 second degree relatives and 6 spouses were investigated. The mean titre of rubella antibodies was significantly higher in the first-degree relatives than in the genetically-unrelated spouses but these high antibody levels were not related to the presence of HLA-B8 (Fig 3) . This is further evidence against the simple inheritance of an immune response gene linked to HLA-B8, but is consistent with the inheritance of a more generalized nonspecific increase in immune responsiveness which is under polygenic control. The patients would have a full complement of the relevant genes and in this setting the effects of HLA-B8 and HLA-B12 would be most evident. In the family members, the genes would be split up and the effect of HLA-B8 or HLA-B12 to increase antibody levels in some of the individuals might be similar in magnitude to the effect of other genes, not HLA-linked, which other family members had inherited. The overall effect would be to produce, on average, antibody levels in the first degree relatives which were less than those in the patients but more than those in the unrelated spouses. This is well illustrated in Fig 3, which also demonstrates that the antibody levels in the few second-degree relatives tested were intermediate between those in the first-degree relatives and the spouses, further supporting this concept of polygenic control of antibody levels. A comparable animal model is that described by Stiffel et al. (1974) in which mice were selectively bred for high and low antibody response to erythrocyte antigens. High and low responders were found to differ genetically at approximately ten loci, at least one of which was histocompatibility-linked. The phenotypic expression I n of some of these genes has been identified in the mice, where, for example, macrophage handling of antigen is different in the high and low line animals (Stiffel et al. 1974) . In man, however, the mechanisms responsible for the increased antibody levels are almost completely unknown. In our own family study, the inheritance of the tendency to acquire circulating antibodies reacting with smooth muscle and nuclear antigens was clearly independent of both HLA-B8 and the height of the antibody response to rubella (Fig 3) , but is probably another of the genetic ingredients of HBsAgnegative chronic active hepatitis. Allison et al. (1971) suggested that a defect in the activity of suppressor T cells may be of central importance in the persistence of autoimmune reactions and thus the pathogenesis of autoimmune tissue injury. We postulated that HLA-B8 might be a marker for such an abnormality in the control of immune responses (Eddleston & Williams 1974) and that this defect could be the link between the many different HLA-B8 associated diseases (Table 1) . A suppressor T-cell defect would result in a failure to switch off immune responses adequately, but only when combined with a powerful switch-on mechanism would it lead to very high antibody levels. The parallelism between this predicted behaviour and the actual findings in the patients with chronic active hepatitis and their relations, is remarkably close. Direct measurements of suppressor T-cell function in man are just beginning to be made and this hypothesis will hopefully soon be proved or refuted. Two recent pieces of clinical evidence are at least consistent with this concept of the HLA-B8 associated defect. The first concerns studies of patients with juvenile-onset diabetes mellitus, where HLA-B8 has been found to be associated not so much with the presence of antibodies reacting with pancreatic islet cells, but with the persistence of these antibodies for many years after the onset of the disease (Morris et al. 1976 ). The second emerges from a careful study by Turner et al. (1977) of the association between particular histocompatibility antigens and the various clinical manifestations of allergy. Patients with HLA-Al and HLA-B8 tended to have early onset multisystem atopy characterized by eczema, asthma and hay fever, while in later onset atopy, as exemplified by hay fever alone, there was a relative deficiency of these particular histocompatibility antigens.
The recognition that 'turn off' and 'turn on' may be under independent genetic control implies that the predisposition to autoimmunity may be inherited quite separately from the genetic factors determining the severity and pattern of the autoimmune assault. The case summarized in Table 2 exemplifies this point. This man has multiple immune-mediated disorders but has extremely easily controlled disease. His liver biopsy on treatment shows no evidence of piecemeal necrosis ofperiportal hepatocytes, however two attempts to withdraw steroids have led to relapses with biochemical and histological changes typical of chronic active hepatitis. Histocompatibility testing showed the presence of HLA-A1 and HLA-B8 only, but the titres of rubella and measles antibodies were both very low at less than 1/20, smooth muscle antibody was only just detected at a titre of 1/10 and serum samples have been consistently negative for antinuclear antibodies. Thus, if the hypothesis outlined earlier is correct, he has inherited very poor 'switch off' mechanisms but fortunately has also been endowed with poor 'switch on'. This combination would explain both the multisystem involvement with frequent relapses and the ease of control by steroids. A further inference from this case may be that the rubella and measles antibody titres are not just epiphenomena but may reflect the intensity of the autoimmune assault against hepatocytes, which we have shown is antibody-mediated (Cochrane et al. 1976 ). This is supported by the findings in a group of 45 patients with HBsAg-negative chronic active hepatitis who have been receiving immunosuppressive therapy for at least one year (Fig 4) . There is a significant relationship (P < 0.02) between the rubella antibody titre and the most recent serum aspartate aminotransferase value, a measure of liver cell damage.
Conclusion I have drawn together some of the evidence which suggests that there is an inherited immune hyperreactivity in many patients with chronic active hepatitis and have suggested one possible way in which the histocompatibility antigen, HLA-B8, could contribute to this defect in the control of immune responses. The hope for the future must be that by understanding the nature of this defect it will be possible to devise effective and specific treatment. The very rapid progress being made by basic immunologists in understanding the molecular basis of lymphocyte interactions must be bringing such pipe dreams much closer to reality.
